Literature DB >> 25102448

Serum irisin levels and thyroid function--newly discovered association.

Marek Ruchala1, Ariadna Zybek2, Ewelina Szczepanek-Parulska2.   

Abstract

Irisin is a newly discovered adipo-myokin, which is reported to have a significant influence on the body metabolism and thermogenesis. Other influencing factors on metabolic state are thyroid hormones, which increase heat production and control the energy balance. Due to numerous similarities in action it seems imperative to explore these substances' potential mutual influence on the body. The aim of the study is to provide the first ever, according to our knowledge, evaluation of serum irisin concentrations in patients with thyroid dysfunction and its correlation with creatine kinase (CK) levels - a serum marker of muscle damage. The studied group consisted of 20 patients with newly diagnosed thyroid disorder - hyperthyroidism or hypothyroidism. Venous blood samples were analyzed for irisin, thyrotropin (TSH), free thyroxine (FT4), free triiodothyronine (FT3) and CK serum concentrations. Patients' body mass index (BMI), body weight and muscle mass were evaluated using bioelectrical impedance analysis (BIA). Median serum irisin levels were lower in hypothyroid (117.30ng/ml) than hyperthyroid (161.95ng/ml) patients with a borderline statistical significance (p=0.0726). The negative correlation between irisin and TSH levels was demonstrated (r=-0.4924, p=0.0230), as well as the positive correlation between irisin and FT4 levels (r=0.4833, p=0.0360). The CK level was negatively correlated with irisin, FT4 and FT3 concentrations (r=-0.7272, p=0.0140; r=-0.9636, p=<0.0001; r=-0.8838, p=0.0007, respectively). The study demonstrates that irisin concentrations may vary according to the thyrometabolic state, which potentially could be related to the degree of muscle damage.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hyperthyroidism; Hypothyroidism; Irisin; Thyroid function

Mesh:

Substances:

Year:  2014        PMID: 25102448     DOI: 10.1016/j.peptides.2014.07.021

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

Review 1.  Does iris(in) bring bad news or good news?

Authors:  Silvio Buscemi; Davide Corleo; Carola Buscemi; Carla Giordano
Journal:  Eat Weight Disord       Date:  2017-09-20       Impact factor: 4.652

2.  Irisin levels increase after treatment in patients with newly diagnosed Hashimoto thyroiditis.

Authors:  Z A Uc; S Gorar; S Mizrak; S Gullu
Journal:  J Endocrinol Invest       Date:  2018-05-18       Impact factor: 4.256

3.  Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors.

Authors:  Theodora Stratigou; Maria Dalamaga; Georgios Antonakos; Ioanna Marinou; Evaggelos Vogiatzakis; Gerasimos Socrates Christodoulatos; Irene Karampela; Athanasios G Papavassiliou
Journal:  Endocrine       Date:  2018-02-17       Impact factor: 3.633

4.  Elevated serum neuregulin 4 levels in patients with hyperthyroidism.

Authors:  Min Li; Ying Chen; Jingjing Jiang; Yan Lu; Zhiyi Song; Shengjie Zhang; Chao Sun; Hao Ying; Xiaofang Fan; Yuping Song; Jialin Yang; Lin Zhao
Journal:  Endocr Connect       Date:  2019-06-01       Impact factor: 3.335

5.  The Effect of Pubertal Stage on the Concentrations of the Novel Adipomyokine, Irisin, in Male Adolescents

Authors:  Demet Taş; Alkım Akman Öden; Sinem Akgül; Ziya E. Metin; Aslı Pınar; Nuray Kanbur
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-09-13

6.  Irisin as a Potential Biomarker Associated with Myocardial Injuries in Patients with Severe Hypothyroidism.

Authors:  Zhi Yao; Xiaoyu Ding; Xia Gao; Ning Yang; Yumei Jia; Jia Liu; Guang Wang
Journal:  Int J Endocrinol       Date:  2021-11-18       Impact factor: 3.257

7.  Myokines in Acromegaly: An Altered Irisin Profile.

Authors:  Łukasz Mizera; Jowita Halupczok-Żyła; Katarzyna Kolačkov; Agnieszka Zembska; Jędrzej Grzegrzółka; Diana Jędrzejuk; Marek Bolanowski; Jacek Daroszewski
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-02       Impact factor: 5.555

8.  Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study.

Authors:  V Guarnotta; G Pillitteri; G Gambino; S Radellini; E Vigneri; G Pizzolanti; C Giordano
Journal:  J Endocrinol Invest       Date:  2020-10-24       Impact factor: 4.256

9.  Elevated Serum Growth Differentiation Factor 15 Levels in Hyperthyroid Patients.

Authors:  Jiejie Zhao; Min Li; Ying Chen; Shengjie Zhang; Hao Ying; Zhiyi Song; Yan Lu; Xiaoying Li; Xuelian Xiong; Jingjing Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-09       Impact factor: 5.555

10.  Circulating Irisin Level and Thyroid Dysfunction: A Systematic Review and Meta-Analysis.

Authors:  Dan Shan; Li Zou; Xijiao Liu; Yitong Cai; Ruihong Dong; Yayi Hu
Journal:  Biomed Res Int       Date:  2020-10-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.